Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.

To evaluate the ability of contrast enhanced ultrasound (CEUS) in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma (HCC) in comparison with contrast enhanced computed tomography (CECT) and/or magnetic resonance imaging (CEMRI). A total of 151 patients were enrolled in the study. Before the radio-frequency (RF) or microwave ablation treatment, tumor vascularity was assessed in 139 patients with three imaging modalities i.e., US (139 exams), CEUS (139 exams) and CECT (103 exams)/CEMR (36 exams). CEUS examination was performed using a sulphur hexafluoride-filled microbubble contrast agent (SonoVue((R)), Bracco, Milan, Italy) and real-time contrast-specific imaging techniques. Within 30 +/- 7 d after the ablation procedure, 118/139 patients were monitored to assess the tumor response to treatment. Before ablation, contrast enhancement within tumor was observed in 129/139 (92.8%) patients with CEUS and 133/139 (95.7%) patients with CECT/CEMRI. Compared with CECT/CEMRI, CEUS sensitivity and accuracy in detecting tumor vascularity were 97.0% and 94.2%, respectively. One month after treatment, no enhancement was seen in 110/118 (93.2%) both on CEUS and CECT/CEMRI. Concordance between CEUS and CECT/CEMR on the presence of residual vascularization was obtained in four patients (true positive). The specificity and accuracy of CEUS in detecting tumor vascularity were 98.2% and 96.6%, respectively. The periprocedural impact of SonoVue administration on the assessment of treatment extent was also evaluated in a subgroup of patients and CEUS showed its superiority compared with baseline US in defining treatment outcome. In conclusion, in the detection of HCC tumor vascularity and assessment of response to thermal ablation after 1 month, real time CEUS provided results comparable to those obtained with CECT/CEMRI. CEUS examination proved to be a safe and easy to access procedure, with potential for diagnostic impact in the clinical practice.

[1]  S Nahum Goldberg,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria. , 2005, Radiology.

[2]  L J Liang,et al.  Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. , 2001, Radiology.

[3]  S. Goldberg,et al.  Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. , 2001, AJR. American journal of roentgenology.

[4]  D. Choi,et al.  Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. , 2001, Radiology.

[5]  M. Oudkerk,et al.  Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. , 2006, World journal of gastroenterology.

[6]  T. Livraghi,et al.  Radiofrequency Ablation of Liver Tumors: The Role of Microbubble Ultrasound Contrast Agents , 2006, Ultrasound quarterly.

[7]  B. Choi,et al.  Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results. , 1998, Radiology.

[8]  W. Lau,et al.  Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma: A Review and Look Into the Future , 2003, Annals of surgery.

[9]  Young Han Kim,et al.  Early Assessment of the Therapeutic Response to Radio Frequency Ablation for Hepatocellular Carcinoma , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[10]  J. Han,et al.  Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures , 2002, Abdominal Imaging.

[11]  P. Petrow,et al.  Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. , 2002, Radiology.

[12]  H. Ueno,et al.  Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. , 2001, Japanese journal of clinical oncology.

[13]  S. Nahum Goldberg,et al.  The role of contrast-enhanced ultrasound in the detection of focal liver leasions , 2001, European Radiology.

[14]  Thomas Albrecht,et al.  Charakterisierung fokaler Leberläsionen mit kontrastmittelgestütztem „low MI real time” Ultraschall und SonoVue , 2003 .

[15]  Carlo Bartolozzi,et al.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. , 2003, Radiology.

[16]  T. Livraghi,et al.  Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. , 1999, AJR. American journal of roentgenology.

[17]  Z. Tang,et al.  Hepatocellular carcinoma--cause, treatment and metastasis. , 2001, World journal of gastroenterology.

[18]  J. H. Lim,et al.  Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. , 2005, European journal of radiology.

[19]  M. Di Stasi,et al.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results , 2001, European Radiology.

[20]  Young Han Kim,et al.  Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[21]  H-X Xu,et al.  Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. , 2004, Clinical radiology.

[22]  L. Solbiati,et al.  Monitoring RF ablation , 2004, European radiology.

[23]  Jing Zhang,et al.  Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. , 2003, AJR. American journal of roentgenology.

[24]  M. Pompili,et al.  Contrast‐enhanced gray‐scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[25]  L Solbiati,et al.  Guidelines for the use of contrast agents in ultrasound. January 2004. , 2004, Ultraschall in der Medizin.

[26]  G. Ferraioli,et al.  Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. , 2004, AJR. American journal of roentgenology.

[27]  Feng Yan,et al.  BR1: A New Ultrasonographic Contrast Agent Based on Sulfur Hexafluoride-Filled Microbubbles , 1995, Investigative radiology.

[28]  Wei Yang,et al.  Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. , 2004, Radiology.

[29]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[30]  S. Delorme,et al.  Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound—initial results , 2005, European Radiology.

[31]  T. Livraghi,et al.  Radiofrequency thermal ablation of hepatocellular carcinoma. , 2001, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[32]  L Solbiati,et al.  Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience. , 1999, Radiology.

[33]  Marcelo Sánchez,et al.  La ecografia con contraste de segunda generacion (SonoVue) en la valoracion del tratamiento percutáneo del carcinoma hepatocelular. Comparación con la TC multifásica , 2005 .

[34]  S. Fan,et al.  Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective , 2002, Annals of surgery.

[35]  G. Gazelle,et al.  Tumor ablation with radio-frequency energy. , 2000, Radiology.

[36]  Xiao-Yan Xie,et al.  Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study , 2005, Journal of Gastroenterology.

[37]  Emilio Quaia,et al.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. , 2004, Radiology.

[38]  W R Lees,et al.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[39]  G S Gazelle,et al.  Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent. , 1999, Radiology.

[40]  H K Lim,et al.  Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. , 2000, Radiology.

[41]  C. Bartolozzi,et al.  Ultrasound imaging of focal liver lesions with a second-generation contrast agent. , 2002, Academic radiology.

[42]  L Solbiati,et al.  Ablation of liver tumors using percutaneous RF therapy. , 1998, AJR. American journal of roentgenology.

[43]  Luigi Solbiati,et al.  Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. , 2004, European journal of radiology.

[44]  Jun Ding,et al.  Characterization of focal liver lesions: Comparison of pulse‐inversion harmonic contrast‐enhanced sonography with contrast‐enhanced CT , 2007, Journal of clinical ultrasound : JCU.

[45]  F. Izzo,et al.  Levovist-enhanced Doppler Sonography Versus Spiral Computed Tomography to Evaluate Response to Percutaneous Ethanol Injection in Hepatocellular Carcinoma , 2000, Journal of clinical gastroenterology.

[46]  P R Mueller,et al.  Treatment of intrahepatic malignancy with radiofrequency ablation , 2000, Cancer.

[47]  S. Goldberg,et al.  Minimally Invasive Image-Guided Therapies for Hepatocellular Carcinoma , 2002, Journal of clinical gastroenterology.

[48]  H. Sekihara,et al.  Contrast‐enhanced, wide‐band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.